Blood lead screening is essential for protecting our children's health through early detection and intervention.
Lead exposure, even at low levels, can have profound and enduring consequences for a child's health and development. Cognitive delays, behavioral disturbances, and learning difficulties may persist into adulthood. We must take immediate action to prevent these harmful effects.
We urge all healthcare providers to take the necessary steps to comply with the blood lead screening requirements and protect the health of our children. You play a vital role in ensuring children receive blood lead screenings. Remember, you are the first line in this crucial process.
Screening Periods:
- 12 months: Initial screening for lead exposure.
- 24 months: Follow-up to monitor ongoing risks.
- Up to 72 months: For children who missed earlier screenings or remain at risk.
By complying with DHCS and CMS regulations for each period, you are actively preventing the harmful effects of lead exposure. The Department of Health Care Services (DHCS) requires these screenings for Medi-Cal members under the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) program.
Providers must document screening discussions in the member’s chart. If a parent declines, a signed refusal form must be included in the member’s records.
L.A. Care Health Plan posts monthly reports on the provider portal showing members missing blood lead screenings. Offices should use these reports to identify and follow up with members needing screenings.
For more information, refer to the CDC Childhood Lead Poisoning Prevention Program or email us.